Literature DB >> 15187166

Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus.

Sandeep Krishnan1, Madhusoodana P Nambiar, Vishal G Warke, Carolyn U Fisher, Jeanne Mitchell, Nancy Delaney, George C Tsokos.   

Abstract

In response to appropriate stimulation, T lymphocytes from systemic lupus erythematosus (SLE) patients exhibit increased and faster intracellular tyrosine phosphorylation and free calcium responses. We have explored whether the composition and dynamics of lipid rafts are responsible for the abnormal T cell responses in SLE. SLE T cells generate and possess higher amounts of ganglioside-containing lipid rafts and, unlike normal T cells, SLE T cell lipid rafts include FcRgamma and activated Syk kinase. IgM anti-CD3 Ab-mediated capping of TCR complexes occurs more rapidly in SLE T cells and concomitant with dramatic acceleration of actin polymerization kinetics. The significance of these findings is evident from the observation that cross-linking of lipid rafts evokes earlier and higher calcium responses in SLE T cells. Thus, we propose that alterations in the lipid raft signaling machinery represent an important mechanism that is responsible for the heightened and accelerated T cell responses in SLE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187166     DOI: 10.4049/jimmunol.172.12.7821

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

Review 1.  T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens.

Authors:  Syamal K Datta; Li Zhang; Luting Xu
Journal:  J Mol Med (Berl)       Date:  2005-01-04       Impact factor: 4.599

Review 2.  New insights into the pathogenesis of systemic lupus erythematosus.

Authors:  Vasileios C Kyttaris; Christina G Katsiari; Yuang-Taung Juang; George C Tsokos
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

3.  T cell activation by terminal complex of complement and immune complexes.

Authors:  Anil K Chauhan; Terry L Moore
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

Review 4.  Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.

Authors:  Mohammed M Al Gadban; Mohamed M Alwan; Kent J Smith; Samar M Hammad
Journal:  Clin Immunol       Date:  2015-01-28       Impact factor: 3.969

5.  Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.

Authors:  Stella A Nicolaou; Peter Szigligeti; Lisa Neumeier; Susan Molleran Lee; Heather J Duncan; Shashi K Kant; Anne Barbara Mongey; Alexandra H Filipovich; Laura Conforti
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

Review 6.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

7.  Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus.

Authors:  Stella A Nicolaou; Lisa Neumeier; Koichi Takimoto; Susan Molleran Lee; Heather J Duncan; Shashi K Kant; Anne Barbara Mongey; Alexandra H Filipovich; Laura Conforti
Journal:  Cell Calcium       Date:  2009-12-02       Impact factor: 6.817

8.  Lipids rule: resetting lipid metabolism restores T cell function in systemic lupus erythematosus.

Authors:  Yoko Kidani; Steven J Bensinger
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

Review 9.  Small molecules in the treatment of systemic lupus erythematosus.

Authors:  Anastasia Markopoulou; Vasileios C Kyttaris
Journal:  Clin Immunol       Date:  2012-10-02       Impact factor: 3.969

10.  Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation.

Authors:  Guo-Min Deng; George C Tsokos
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.